How one man was ready to hear he had type 2 diabetes, and how this experience prepared him for life with type 1 diabetes.

PBM executives will also be there to answer questions. Here’s how you can watch and follow the hearing live.

After experiencing two type 1 diabetes diagnoses, the Ohmer family is hoping to empower other families in similar situations.

Read the prepared testimony from executives from Novo Nordisk and Sanofi.

The goal is to gather data to prove the safety and effectiveness of the algorithm, which Tidepool hopes to bring before the FDA for approval.

He outlines how the FDA will move to regulate insulin to encourage competition and drive down prices. Here are five key takeaways from the commissioner’s statement.

A congressional hearing is being held by the House Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce specifically on insulin pricing. Representatives from ADA, JDRF, and DPAC are all expected to testify. Follow along live.

A father’s desire to keep his daughter safe at school leads to an algorithm to predict blood glucose trends for those who use multiple daily injections.

An overview of all the potential threats to insulin from temperature variability, from the butter drawer in your fridge to the mail-order package baking on your front porch.

An interview with pediatric endocrinologist Dr. Mark Clements of Children’s Mercy Hospital in Kansas City. Dr. Clements sits on the IT subcommittee for the T1D Exchange Quality Improvement Collaborative.